# STENDRA
> **NDA202276** · New Drug Application · Sponsor: VIVUS LLC · Approved 2012-04-27
## Drug
- **FDA Application Number:** NDA202276
- **Application type:** New Drug Application
- **Brand name:** STENDRA
- **Generic name:** Avanafil
- **Active ingredients:** AVANAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIVUS LLC
- **First approval:** 2012-04-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276)
---
*MORVS · CC0 1.0*